Related Experiment Video

Updated: Oct 7, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.3K

The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

Emelie C Rotbain1,2,3,4,5, Max J Gordon6, Noomi Vainer1

  • 1Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

Blood Advances
|January 10, 2022
PubMed

Insights

The chronic lymphocytic leukemia comorbidity index (CLL-CI) effectively predicts outcomes in CLL patients. This tool assesses risk based on vascular, gastrointestinal, and endocrine systems, aiding treatment decisions.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Prognostics

Background:

  • Chronic lymphocytic leukemia (CLL) requires prognostic tools for patient management.
  • The Cumulative Illness Rating Scale (CIRS) is a general comorbidity assessment tool.
  • A CLL-specific index is needed to accurately predict outcomes.

Purpose of the Study:

  • To validate the prognostic utility of the CLL-CI in a large, population-based CLL cohort.
  • To assess the association of CLL-CI with overall survival (OS) and event-free survival (EFS).
  • To determine if CLL-CI provides prognostic information independent of the CLL International Prognostic Index (CLL-IPI).

Main Methods:

  • Utilized a population-based cohort of 4975 CLL patients.
  • Applied the CLL-CI, assessing vascular, upper gastrointestinal, and endocrine organ systems.
  • Analyzed associations between CLL-CI risk categories and survival outcomes (OS, EFS).
  • Performed multivariate analysis comparing CLL-CI with CLL-IPI.

Main Results:

  • The CLL-CI demonstrated significant prognostic value for OS and EFS from therapy initiation.
  • CLL-CI independently predicted OS, EFS, and time to first treatment from diagnosis.
  • Prognostic significance of CLL-CI was maintained across different risk categories.
  • CLL-CI provided additional prognostic information beyond the CLL-IPI.

Conclusions:

  • The CLL-CI is a validated, prognostic tool for CLL patients in a large cohort.
  • CLL-CI aids in risk stratification and predicting outcomes in CLL.
  • The findings support the integration of CLL-CI into clinical practice and research for CLL management.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Related Concept Videos

Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
191
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
912
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
870